sh logo mobile
Stamford Health

ECOG-ACRIN-EA5221

Back to Results

A Randomized Phase III Trial of Chemo-Immunotherapy vs Immunotherapy Alone for the Vulnerable older adult with Advanced Non-Small Cell Lung Cancer: The ACHIEVE Study

A Randomized Phase III Trial of Chemo-Immunotherapy vs Immunotherapy Alone for the Vulnerable older adult with Advanced Non-Small Cell Lung Cancer: The ACHIEVE Study

Protocol#: EA5221

 

Contact

Clinical Trials Office at [email protected] or (203) 358-8879.


Principal Investigator(s)

Salvatore Del Prete, MD

Sponsor(s)

ECOG-ACRIN

Location

Bennett Cancer Center
One Hospital Plaza
Stamford, CT 06902
Main: 203-358-8879

Our website uses cookies

This website uses cookies to give you the very best experience. Your continued use of this site is considered permission by you to use cookies in this manner. Please review our Privacy Policy and Terms of Use for more information about the data we collect and the types of cookies we use. Please note, if you link off our website to a 3rd party site of any kind, that website has its own terms and conditions.

ACCEPT AND CLOSE